Phocas Financial Corp. Takes Position in Option Care Health, Inc. $OPCH
Phocas Financial Corp. has acquired a new stake of 130,667 shares, valued at approximately $4.16 million, in Option Care Health (NASDAQ:OPCH). This investment represents about 0.08% of the company's shares. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $37.27, following a recent quarter where Option Care Health met or exceeded earnings and revenue expectations.
Expanded Buyback And Credit Facility Might Change The Case For Investing In Option Care Health (OPCH)
Option Care Health (OPCH) recently expanded its revolving credit facility by US$450 million to US$850 million and increased its share repurchase authorization to US$1 billion, while reaffirming its 2026 guidance. This move enhances liquidity and signals management's confidence in cash generation, offering greater flexibility for growth and capital returns. Despite these positive developments, investors should remain aware of potential challenges such as reimbursement pressures and payer consolidation.
Option Care Health (OPCH) lifts revolving credit commitments to $850,000,000
Option Care Health, Inc. (OPCH) has increased its revolving credit commitments by $450 million, bringing the total capacity under its amended First Lien Credit Agreement to $850 million. This amendment, dated March 30, 2026, expands the company's committed borrowing capacity with Bank of America, N.A. as the administrative agent. The change is classified as a material definitive agreement and the creation of a direct financial obligation, providing a balance sheet and liquidity tool for the company.
Option Care Health and Nexstar Media are the most oversold among U.S. mid-cap stocks (IJH:NYSEARCA)
Option Care Health and Nexstar Media are identified as the most oversold mid-cap stocks in the U.S. based on their Relative Strength Index (RSI). This list, which also includes companies like Wingstop and ADMA Biologics, suggests potential rebound candidates across various sectors such as healthcare, media, food, biotech, and real estate, as an RSI below 30 often signals an oversold condition.
Assenagon Asset Management S.A. Sells 256,637 Shares of Option Care Health, Inc. $OPCH
Assenagon Asset Management S.A. significantly reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 87.2% in Q4, selling 256,637 shares and retaining 37,761 shares valued at $1.203 million. Other institutional investors like Cornerstone Planning Group and Hantz Financial Services Inc. increased their positions. Analyst ratings for OPCH are generally positive, with a "Moderate Buy" consensus and an average target price of $37.27, following the company's Q4 earnings results that met expectations.
Behavioral Patterns of OPCH and Institutional Flows
This article analyzes Option Care Health Inc. (NASDAQ: OPCH), highlighting weak near and mid-term sentiment and a neutral long-term outlook. It presents AI-generated trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The analysis suggests elevated downside risk due to a lack of additional long-term support signals.
MIL:1OPCH PB Ratio: 3.19 — 14% Below Median
Option Care Health Inc (MIL:1OPCH) has a Price-to-Book (PB) Ratio of 3.19 as of March 28, 2026, which is 14% below its 10-year median but 63.6% above the Healthcare Providers & Services industry median. Despite being below its historical median, the stock's PB Ratio places it in the lower half of its industry. GuruFocus assesses MIL:1OPCH as undervalued, with a GF Score of 87/100 and its current price of €23.00 trading significantly below its GF Value™ of €35.63.
Vanguard disaggregates holdings; OPCH (NASDAQ: OPCH) shows 0% ownership
The Vanguard Group filed an Amendment No. 4 to Schedule 13G/A for Option Care Health Inc (OPCH), reporting 0% beneficial ownership following an internal realignment. This change is due to certain Vanguard subsidiaries now reporting their holdings separately, in reliance on SEC Release No. 34-39538. Investors should note this does not mean Vanguard affiliates hold no OPCH shares, but rather that individual subsidiaries will file their own reports.
Option Care Health, Inc. $OPCH Shares Sold by Riverbridge Partners LLC
Riverbridge Partners LLC decreased its stake in Option Care Health (NASDAQ:OPCH) by 12.7% in the fourth quarter, reducing its holdings to 1,262,553 shares valued at approximately $40.2 million. Despite this, other institutional investors have increased their positions. Option Care Health reported strong Q4 results with EPS of $0.46 and revenue of $1.47 billion, exceeding analyst expectations, and analysts generally maintain a "Moderate Buy" rating for the stock with an average price target of $37.27.
Fort Washington Investment Advisors Inc. OH Grows Position in Option Care Health, Inc. $OPCH
Fort Washington Investment Advisors Inc. OH increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 13.1% in Q4, now owning 0.91% of the company worth $45.8 million. Other institutional investors like RBC and AQR also expanded their positions, with institutional ownership reaching 98.05%. Option Care Health recently reported Q4 EPS of $0.46, matching estimates, and revenue of $1.47 billion, an 8.8% year-over-year increase, and currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $37.27.
Option Care Health, Inc. $OPCH Shares Sold by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL significantly reduced its stake in Option Care Health (NASDAQ:OPCH) by 38.3% in the third quarter, selling over 108,000 shares. Despite this, other hedge funds increased their positions in the company, and analysts maintain a "Moderate Buy" rating with a consensus price target of $37.27. Option Care Health reported solid quarterly earnings, meeting analyst estimates for EPS and exceeding revenue expectations.
JPMorgan Chase & Co. Sells 439,421 Shares of Option Care Health, Inc. $OPCH
JPMorgan Chase & Co. recently reduced its stake in Option Care Health, Inc. by 36.8%, selling 439,421 shares and holding 754,845 shares. This adjustment leaves JPMorgan with approximately 0.48% ownership, valued at about $20.95 million. Despite the sale, Option Care Health maintains a "Moderate Buy" consensus rating from analysts with an average price target of $37.27, following a strong earnings report where the company met EPS estimates and exceeded revenue expectations with 8.8% year-over-year growth.
OPCH PE Ratio & Valuation, Is OPCH Overvalued
This article analyzes the valuation of Option Care Health Inc (OPCH), concluding that it is currently undervalued. Based on its forward PE ratio of 21.79 compared to a five-year average of 27.47, the fair price is estimated to be between $48.91 and $60.19, significantly higher than its current price of $28.16. The report also details other valuation metrics like P/B ratio and FCF yield, and compares OPCH's P/S ratio to its competitors.
Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Rating of "Moderate Buy" from Brokerages
Option Care Health, Inc. (NASDAQ:OPCH) has received a "Moderate Buy" consensus rating from eleven brokerages, with an average 1-year price target of $37.27. The company recently reported Q4 EPS of $0.46, matching consensus, and revenue of $1.47 billion, slightly above estimates and up 8.8% year-over-year. Shares recently traded at $29.66, and institutional investors own approximately 98.05% of the stock.
Option Care Health Q4 2025 earnings preview
This article previews Option Care Health's Q4 2025 earnings. Due to the limited content, specific financial expectations or details are not available.
Option Care Health outlines $5.8B–$6B 2026 revenue guidance while expanding infusion clinic network
Option Care Health announced its financial outlook for 2026, projecting revenues between $5.8 billion and $6 billion. The company plans to expand its network of infusion clinics to between 175 and 185 by 2026. This expansion and revenue guidance signal anticipated growth in the home and alternate site infusion services market.
4 Outpatient Home Care Stocks Attracting Interest as Market Dynamics Change
The outpatient and home healthcare sector is experiencing significant growth driven by an aging population, cost savings initiatives, and technological advancements like AI and telehealth. The global home healthcare market is projected to reach $747.7 billion by 2030. Companies like DaVita Inc. (DVA), Quest Diagnostics Incorporated (DGX), Option Care Health, Inc. (OPCH), and Addus HomeCare Corporation (ADUS) are well-positioned to capitalize on these trends.
Game Creek Capital LP Purchases New Shares in Option Care Health, Inc. $OPCH
Game Creek Capital LP has acquired a new stake of 55,000 shares in Option Care Health, Inc. (NASDAQ:OPCH) during the third quarter, valued at approximately $1.53 million. Other institutional investors also adjusted their holdings in the company, which now sees 98.05% of its stock owned by hedge funds and institutions. Option Care Health reported earnings per share of $0.46, meeting analyst consensus, and analysts forecast $1.22 EPS for the current year.
Schroder Investment Management Group Has $27.22 Million Holdings in Option Care Health, Inc. $OPCH
Schroder Investment Management Group significantly reduced its stake in Option Care Health (NASDAQ:OPCH) by 29.2% in the third quarter, holding 988,299 shares valued at $27.22 million. Despite this, institutional investors collectively own about 98.05% of the company's stock. Option Care Health has a "Moderate Buy" consensus rating from analysts with a target price of $37.27, and recently reported in-line Q earnings per share of $0.46 and an 8.8% year-over-year revenue increase to $1.47 billion.
Option Care Health, Inc. $OPCH Shares Bought by Victory Capital Management Inc.
Victory Capital Management Inc. significantly increased its stake in Option Care Health (NASDAQ:OPCH) during the third quarter, acquiring an additional 216,489 shares, bringing its total to 383,605 shares valued at approximately $10.65 million. Other institutional investors also adjusted their positions, indicating high institutional ownership (98.05%). The company reported Q3 EPS of $0.46, matching estimates, with revenue up 8.8% year-over-year, and analysts maintain a "Moderate Buy" consensus rating with an average price target of $37.27.
Option Care Health, Inc. $OPCH Shares Acquired by Geneva Capital Management LLC
Geneva Capital Management LLC significantly increased its stake in Option Care Health ($OPCH) by 27.6% in the third quarter, acquiring an additional 296,216 shares. Major institutional investors and hedge funds now own 98.05% of the company's stock. Wall Street analysts maintain a "Moderate Buy" consensus rating with an average target price of $37.27 for OPCH.
Quantbot Technologies LP Sells 75,666 Shares of Option Care Health, Inc. $OPCH
Quantbot Technologies LP significantly reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 84.0% in the third quarter, selling 75,666 shares and retaining 14,412 shares valued at $400,000. Option Care Health recently reported Q3 EPS of $0.46 and revenue of $1.47 billion, an 8.8% year-over-year increase, with analysts holding a "Moderate Buy" consensus rating and an average price target of $37.27. The company's stock has shown recent volatility, with several other hedge funds adjusting their positions, and 98.05% of the stock is owned by institutional investors.
Gamco Investors INC. ET AL Boosts Stock Holdings in Option Care Health, Inc. $OPCH
Gamco Investors INC. ET AL significantly increased its stake in Option Care Health (NASDAQ:OPCH) by 210.3% in the third quarter of 2025, now holding 269,758 shares valued at approximately $7.49 million. Institutional ownership of OPCH is high at 98.05%, with several other firms also expanding or initiating positions. Analysts maintain a "Moderate Buy" consensus rating with a target price of $37.27, following the company's Q4 earnings which met EPS expectations and reported an 8.8% year-over-year revenue increase.
Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know
Shares of Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea fell after a February jobs report indicated an unexpected contraction in employment, particularly in the healthcare sector. The economy lost 92,000 nonfarm payroll jobs, with 28,000 positions shed in healthcare, leading to investor concerns about reduced healthcare spending. Neogen, despite recent strong Q4 results and increased guidance, was among the affected stocks.
Teachers Retirement System of The State of Kentucky Sells 51,385 Shares of Option Care Health, Inc. $OPCH
The Teachers Retirement System of The State of Kentucky reduced its stake in Option Care Health (NASDAQ:OPCH) by 51.5% in the third quarter of 2025, selling 51,385 shares and leaving them with 48,325 shares valued at $1.34 million. Despite this sale, other institutional investors, including Swedbank AB, Boston Partners, and Prudential Financial Inc., significantly increased their holdings, bringing the total institutional ownership to 98.05%. Option Care Health recently reported Q4 EPS of $0.46 and revenue of $1.47 billion, with analysts giving it an average "Moderate Buy" rating and a mean target price of $37.27.
Option Care Health Inc (OPCH) Shares Down 3.9% on Mar 4
Option Care Health Inc (OPCH) shares dropped 3.90% on March 4th, trading at an intraday low of $29.54 before closing at $29.98. This places the stock significantly below its 52-week high, with analysts forecasting an average target price of $40.10, implying an upside of 33.74%. GuruFocus estimates the fair value (GF Value) at $46.29, suggesting an even greater upside of 54.38%.
Option Care Health (OPCH) HR chief sells 6,000 shares at $33
Michael Bavaro, Chief Human Resources Officer of Option Care Health, Inc. (OPCH), sold 6,000 shares of company common stock at $33.00 per share in an open-market transaction. Following this sale, Bavaro directly owns 33,249 shares of OPCH. This insider trading activity was reported via a Form 4 filing with the SEC.
Option Care Health Director Sells Over 30,000 Shares
Option Care Health Director Pate R Carter sold 30,287 shares of Common Stock on February 27, 2026, for a total of $970,619. The shares were sold at a weighted average price of $32.0474 per share. Following this transaction, Carter directly owns 11,623 shares of the company.
EEOC, Health Co. Reach Accord In Pregnancy Bias Suit
The U.S. Equal Employment Opportunity Commission (EEOC) has reached a tentative agreement with an infusion therapy provider to resolve a lawsuit alleging pregnancy discrimination. The lawsuit accused the company of unlawfully denying a pregnant nurse's requests related to her pregnancy. Further details of the settlement or the specific nature of the nurse's requests are not available in the provided excerpt, which directs readers to register for the full article.
JPMorgan Chase & Co. Cuts Holdings in Option Care Health, Inc. $OPCH
JPMorgan Chase & Co. reduced its stake in Option Care Health, Inc. by 36.8% in Q3, selling 439,421 shares and retaining 754,845 shares valued at approximately $20.95 million. Despite this, institutional ownership of OPCH remains high at 98.05%, with other funds increasing their positions. Analysts maintain a "Moderate Buy" consensus rating with a target price of $37.58, following the company's Q3 earnings report of $0.46 EPS and $1.47 billion in revenue.
Option Care Health (OPCH) Valuation After 2025 Results And Expanded Share Repurchase Program
Option Care Health (OPCH) reported its Q4 and full-year 2025 results, showing higher sales, margin pressure, reaffirmed guidance, and an expanded share repurchase program. Despite recent stock pressure, the company is considered 18.5% undervalued with a fair value of $39.82, according to Simply Wall St's analysis. The article highlights both the optimistic narrative driven by technology investments and efficiency projects, as well as risks such as reimbursement pressure and shifting therapy mix.
Option Care Health, Inc. (OPCH) Investor Outlook: Capitalizing on a 23.51% Potential Upside
Option Care Health, Inc. (OPCH) is highlighted as a strong player in the home and alternate site infusion services industry, showing robust financial health with an 8.80% revenue growth and $172.7 million in free cash flow. Analysts express high confidence in OPCH, with 11 buy ratings and no sell ratings, projecting a 23.51% potential upside from its current price. The company's strategic positioning and efficient management make it an attractive consideration for growth-oriented investors in the healthcare sector.
Citigroup Inc. Sells 124,179 Shares of Option Care Health, Inc. $OPCH
Citigroup Inc. has reduced its stake in Option Care Health, Inc. by selling 124,179 shares, which represents a 26.8% decrease in its holdings. Following this transaction, Citigroup now owns 339,295 shares of OPCH, valued at approximately $9.42 million. Option Care Health reported an EPS of $0.46 and revenue of $1.47 billion, aligning with analyst estimates, and currently holds a "Moderate Buy" consensus rating with an average price target of $37.58.
Option Care Health (OPCH) CMO logs Form 4 tax-withholding share transaction
Option Care Health (OPCH) Chief Medical Officer Adewunmi Femi reported a Form 4 transaction involving the disposition of 1,627 shares of common stock for tax withholding purposes. The transaction occurred on February 24, 2026, at an indicated price of $33.815 per share. Following this tax-related transaction, Femi directly owns 26,710 shares of Option Care Health common stock.
Is OPCH’s Enlarged Buyback and Reaffirmed 2026 Outlook Reframing Its Capital Return Story?
Option Care Health (OPCH) recently reported its Q4 and full-year 2025 results, reaffirming its 2026 outlook and expanding its share repurchase authorization to US$1 billion. This move emphasizes management's focus on capital returns despite pressures from biosimilar adoption and regulatory changes. The article examines how these actions shape the company's investment narrative, particularly concerning capital allocation amidst modest earnings growth and margin pressures.
Intech Investment Management LLC Increases Stock Holdings in Option Care Health, Inc. $OPCH
Intech Investment Management LLC significantly increased its stake in Option Care Health (NASDAQ:OPCH) by 54.2%, acquiring an additional 66,167 shares to total 188,167 shares valued at $5.22 million. Other institutional investors like Cornerstone Planning Group LLC and Hantz Financial Services Inc. also scaled up their holdings. Analysts maintain a "Moderate Buy" consensus rating for Option Care Health, with a target price of $37.58, following recent positive earnings reports.
Option Care Health (NASDAQ: OPCH) Form 144 lists planned Common Stock sales
Option Care Health (NASDAQ: OPCH) has filed a Form 144 detailing proposed sales of Common Stock. The filing indicates multiple future sale entries, including 750 shares on August 20, 2025, and 2,967 shares on May 20, 2025, along with other stock award-related sales from 2022 to 2025. Fidelity Brokerage Services LLC is listed as the broker for these transactions.
OPCH Financials: Income Statement, Balance Sheet & Cash Flow
This article provides a detailed financial overview of Option Care Health Inc (OPCH) as of fiscal year 2025, covering its income statement, balance sheet, cash flow, and key financial ratios. It highlights the company's moderate financial health with solid revenue growth, conservative leverage, and cash-backed earnings, while noting areas like free cash flow margin and operating efficiency. The report synthesizes data from SEC filings, offering insights into profitability, growth, liquidity, and bankruptcy risk.
Option Care Health (OPCH) grows 2025 revenue 13% and guides higher for 2026
Option Care Health (OPCH) reported strong financial results for 2025, with net revenue increasing by 13.0% to $5,649.5 million and Adjusted EBITDA growing 6.2% to $471.3 million. The company also announced a share repurchase program worth $307 million for the year. Looking ahead to 2026, Option Care Health provided optimistic guidance, forecasting net revenue between $5.8 billion and $6.0 billion, and Adjusted EBITDA between $480 million and $505 million, signaling continued growth and profitability.
OPCH (Option Care Health) COO logs tax-withholding disposal of 4,605 shares
Option Care Health, Inc.'s Chief Operating Officer, Luke Whitworth, reported the disposition of 4,605 shares of common stock. These shares, valued at $33.815 each, were transferred to cover tax withholding obligations rather than being sold on the open market. Following this transaction, Whitworth directly holds 169,589 common shares in the company.
Vanguard Group Inc. Sells 330,939 Shares of Option Care Health, Inc. $OPCH
Vanguard Group Inc. reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 1.8% in the last quarter, selling 330,939 shares but still owning over 17.6 million shares valued at approximately $490.98 million. Option Care Health reported Q4 EPS of $0.46, meeting analyst expectations, and revenue of $1.47 billion, an 8.8% year-over-year increase. The company holds a "Moderate Buy" consensus rating from analysts with an average price target of $37.58.
[Form 4] Option Care Health, Inc. Insider Trading Activity
Option Care Health, Inc.'s Chief Accounting Officer, Nicole Maggio, reported a tax-withholding disposition of 975 shares of company common stock on February 24, 2026, valued at $33.815 per share. After this transaction, Maggio directly owned 28,489 shares. This information was disclosed in a Form 4 SEC filing, indicating a neutral impact and sentiment on the company.
Option Care Health, Inc. $OPCH Shares Sold by Westfield Capital Management Co. LP
Westfield Capital Management Co. LP significantly reduced its stake in Option Care Health, Inc. (OPCH) by selling 303,616 shares, though still holding a substantial position. The company reported strong financial results with $0.46 EPS and $1.47 billion in revenue, exceeding analyst expectations. Analysts maintain a "Moderate Buy" rating for OPCH, projecting an average price target of $37.58.
Fox Run Management L.L.C. Invests $1.31 Million in Option Care Health, Inc. $OPCH
Fox Run Management L.L.C. has acquired a new stake of 47,164 shares in Option Care Health, Inc. (NASDAQ:OPCH) valued at approximately $1.31 million. This investment comes as Option Care Health reported Q4 results that met expectations with an EPS of $0.46 and revenue of $1.47 billion, an 8.8% increase year-over-year. Analysts maintain a "Moderate Buy" consensus rating for the company, with an average price target of $37.58.
[144] Option Care Health, Inc. SEC Filing
This SEC filing (Form 144) details the proposed sale of 6,000 shares of Option Care Health, Inc. (OPCH) common stock by an individual, acquired through a stock award on February 26, 2026. The aggregate market value of the shares is $198,000, and they will be sold through Merrill Lynch on NASDAQ, with an approximate sale date of February 27, 2026. The document also includes standard SEC disclaimers and representations of no undisclosed material adverse information.
Option Care Health (OPCH) Margin Compression Challenges Bullish Earnings Narratives
Option Care Health (OPCH) reported its FY 2025 earnings with Q4 revenue of US$1.5 billion and EPS of US$0.37, though its net profit margin eased to 3.7% from 4.2% a year earlier. This margin compression, coupled with Q4 2025 net income being slightly lower than Q4 2024 despite higher revenue, challenges bullish narratives around the company's profitability and long-term earnings expansion. The article suggests investors examine the interplay of therapy mix, pricing, and costs, especially given a high debt load, rather than solely relying on volume growth.
Option Care Health (OPCH) Margin Compression Challenges Bullish Earnings Narratives
Option Care Health (OPCH) has reported FY 2025 earnings with a decrease in net profit margin from 4.2% to 3.7%, despite increased revenue. While the company's valuation appears discounted to its DCF fair value, the margin compression and high debt load present risks that challenge the bullish earnings narratives focused on long-term growth and technology investments. Investors are advised to consider the interplay of therapy mix, pricing, and costs rather than solely volume growth.
Option Care Health Q4 2025 Earnings: Revenue Meets Estimates, Provides 2026 Guidance - News and Statistics
Option Care Health reported Q4 2025 financial results, with revenue of $1.47 billion and non-GAAP EPS of $0.46, both meeting analyst expectations. The company provided 2026 guidance, with adjusted EPS midpoint at $1.87 and EBITDA midpoint at $492.5 million, which aligns with market expectations. Option Care Health is recognized as the largest independent provider of home and alternate site infusion services in the U.S., demonstrating consistent revenue growth.
Earnings call transcript: Option Care Health Q4 2025 results show resilience
Option Care Health (OPCH) reported its Q4 and full-year 2025 earnings, with revenues exceeding expectations at $1.47 billion, despite a slight miss on EPS. The company reaffirmed its 2026 guidance, expecting $5.8 billion-$6 billion in revenue and adjusted EBITDA of $480 million-$505 million, reflecting ongoing challenges from biosimilar adoption but confidence in its strategic growth initiatives and operational efficiencies. Management highlighted strong annual growth, strategic investments in clinical capabilities, and leveraging technology to enhance efficiency amidst market pressures.
Option Care Health Q4 Earnings Assessment
Option Care Health (NASDAQ: OPCH) reported its Q4 earnings, beating estimated EPS by 4.55% with $0.46 against an estimate of $0.44. Revenue increased by $119.00 million compared to the previous year. The company also provided guidance for FY 2026, expecting earnings between $1.82 and $1.92 per share.
